Azitra, Inc.宣布Atr-04项目1/2期试验完成首位患者给药,该项目针对伴有EGFRI相关皮疹的肿瘤患者

美股速递
Aug 27

Azitra, Inc.近日宣布,公司Atr-04项目的1/2期临床试验已完成首位患者给药。该试验项目专门针对患有EGFRI相关皮疹的肿瘤患者群体。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10